® 7.5 "

: Olanzapine Teva ® 7.5 Mg. ?  »
|
-

PER OS

Film Coated Tablets

Acute and maintenance treatment of schizophrenia. Olanzapine Teva?® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva?® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva?® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva?® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

145 71 33187 01

Teva Pharmaceutical Works Private Limited Company, Hungary

04/2011 - 03/2016

.
, .
.
/
Olanzapine 7.5 MG
Blister pvc/opa/al 7 x TABLETS 24
Blister pvc/opa/al 10 x TABLETS 24
Blister pvc/opa/al 14 x TABLETS 24
Blister pvc/opa/al 20 x TABLETS 24
Blister pvc/opa/al 28 x TABLETS 24
Blister pvc/opa/al 30 x TABLETS 24
Blister pvc/opa/al 35 x TABLETS 24
Blister pvc/opa/al 50 x TABLETS 24
Blister pvc/opa/al 56 x TABLETS 24
Blister pvc/opa/al 60 x TABLETS 24
Blister pvc/opa/al 70 x TABLETS 24

*

*

 

.

 
" !
 

? !
 »
278
,